Moreover, after normalization by the corresponding vehicle-treated group, tumor growth under AZD1775 treatment was highly correlated with ODF2L expression in the ovarian cancer PDX, indicating a role for ODF2L in affecting the response to WEE1 inhibition in EOC (Supplemental Figure 7, A and B). The gene discussed is ODF2L; the disease is ovarian carcinoma.